EBOS Healthcare Hospital Newsletter - Vital Med · 6 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]

2 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]

AUSTRALASIAN COLLEGE FOR INFECTION PREVENTION AND CONTROL

NATIONAL CONFERENCE 20128-11 OCTOBER 2012 • SYDNEY, AUSTRALIA

The ACIPC 7th Biennial Conference will take place from 8th October to 11th October 2012 at the Sydney Exhibition and Convention Centre, Darling Harbour, Sydney, Australia. EBOS Healthcare is supporting this premier industry event ; we look forward to seeing you at booths 36 to 39! See page 10 of this newsletter for more details on the ACIPC Conference.

Perioperative Nurses Association Queensland Inc Annual Conference, 20th October 2012 at the Princess Alexandra Hospital in Brisbane. The conference theme this year is a very sporty ‘Go for Gold’. This is to recognise that every day all Perioperative Nurses strive for the best outcomes for their patients and try to reach that gold standard of care.

Conference NewsCome and see us at the following conferences this Spring!

Introducing Kylie Upton, Eschmann Product Manager at EBOS

Kylie has a long standing relationship with EBOS Healthcare. Her first experience with EBOS was over 6 years long; she was a Key Account Manager for the Hospital Division in Queensland representing all EBOS’s hospital products, including Eschmann operating theatre tables and accessories. She says she was fortunate to have a territory where Eschmann was well known and highly respected, enjoyed a high market share, and her customers’ appreciation of the product was infectious. This is where she got her soft spot for the Eschmann brand, which is one of the reasons why she was very happy to return to EBOS in February this year, after a brief experience with another hospital equipment company.

Kylie is now busy in her new role of

Eschmann Product Manager. She says success on State contract and repeat business from the market loyal to EBOS and the Eschmann brand is very exciting to see. She is proud of the service, reliability and quality that EBOS can offer to their customers, and of the solutions that we can provide to face the daily challenges that come up in the theatre environment.

Kylie is looking forward to bringing the Eschmann brand to new heights, and will love to speak with all those interested in knowing more about the Eschmann product range, exclusively distributed by EBOS.

For information on the Eschmann range please contact Kylie.

E: [email protected] Ph: 1800 269 534 Fax: 1800 810 257 Mob: 0412 203 957


Epworth/Mekong Cycling ChallengeOver $30,000 raised for HeartSmart ProgramAndrew McCullum, our Hospital Division’s National Sales Manager, embarked on this fantastic cycling adventure to raise money for the Epworth Healthcare’s Cardiac Program. The challenge saw Andrew and the other cyclists ride through Laos to Cambodia along the Mekong Valley.

At the start of this year EBOS National Sales Manager Andrew McCullum left the comfort of head office behind for an adventure following the immense Mekong River.

In 11 days, the Mekong Cycling Challenge participants rode from Pakse in the south-west of Laos to Phnom Penh, Cambodia’s capital city, an epic journey of nearly 600 kilometres.

The experience, while daunting, saw Andrew riding through remote villages, over the dykes of rice paddies and of course along the banks of the mighty Mekong, all the while meeting locals and avoiding the buffalo!

The trip was organised by the Epworth Medical Foundation to raise funds for the HeartSmart Program, Epworth’s rehabilitation program for patients recovering from a traumatic heart event, such as a heart attack.

With the money going to such a great cause, EBOS Healthcare and major partners Eschmann and Vernacare, took this opportunity to support one of our valued customers and covered the cost of Andrew’s cycling challenge.

In total the trip raised more than $30,000 for the HeartSmart Program, ensuring that recovering cardiac patients at Epworth continue to receive the highest standard of care.

Initially founded as a novel way for cardiac patients to get excited about exercising, the cycling challenge has grown tremendously. After the success of this year’s Challenge, Epworth have organised another South East Asian cycling adventure, this time taking in the Gulf of Thailand, from Bangkok to the stunning island of Koh Samui.

The Gulf of Thailand Cycling Challenge will take place between 15 and 24 February 2013 and costs $5,545 of which $2,500 is tax deductible. This includes airfares, tour leaders, fully maintained bikes, an accompanying support vehicle, most meals and twin-share accommodation.

Rather than pay outright, participants can choose to be sponsored by creating a fundraising profile on the Epworth Medical Foundation’s Everyday Hero website www.everydayhero.com.au.

Please contact the Epworth Medical Foundation on (03) 9426 6131 to register and to learn more about the challenge.

All money raised through the Mekong cycling challenge was put straight to work in the cardiac services at Epworth which, includes the HeartSmart Program - a tailored rehabilitation program for cardiac patients designed to improve lifestyle and minimise risk through diet, exercise and stress management.

Epworth HealthCare is the largest not-for-profit private hospital group in Victoria. Delivering excellence in world-class care to well over 112,000 inpatients and a similar number of outpatients each year, Epworth receives no direct government funding and relies on the generosity of the community to enable it to stay at the forefront of advancements in technology.

MEDIHONEY® Antimicrobial Manuka Honey dressings are a new line of dressings for the management of challenging and stalled wounds.

MEDIHONEY® is a global medical-grade honey-based product for the management of wounds and burns. These dressings contain Leptospermum Honey, a special honey from New Zealand that has beneficial plant-derived properties and is able to maintain its effectiveness even in the presence of wound fluid.

MEDIHONEY® dressings have been shown in several large randomized controlled studies to be effective on hard-to-heal wounds, that have stalled under first line treatment. 1,-7 The range consists of various patented dressings that can manage a wide variety of wound types in a variety of settings.

Since the dressings are antimicrobials, assist in debridement, and help manage moisture balance, MEDIHONEY® dressings can be thought of as “all-in-one’ dressings for effective wound bed preparation. Additionally, since Leptospermum Honey is noted for its ability to be used in all phases of wound healing, placing these dressings as the cornerstones of a wound care formulary can take a great deal of the guess-work out of wound management.

MEDIHONEY® helps to promote healing as it cleanses and debrides due to its high osmolarity and helps to lower overall wound PH. It promotes a moisture-balanced environment conductive to wound healing, and is easy to use, with the potential for extended wear times (depending on level of exudate).1,-7

MEDIHONEY® dressings are available in several formats, including:

� MEDIHONEY® Alignate

� MEDIHONEY® Antibacterial

� MEDIHONEY® Barrier Cream

� MEDIHONEY® Gel Sheet

� MEDIHONEY® Wound Gel

The below woundcare and product selection chart can be used as a reference guide for choosing the appropriate product for your wound site.

[Effective on a variety of etiologies]

helping to make wound

management easier

MEDIHONEY® on left, plain alginate on right WK #3 after initiation of MEDIHONEY®

Steven J. Kavros, DPM: Case #1 of 3 presented at 2008 SAWC

Patient history of Crohn’s disease

Two wounds were both managed with systemic steroids, light compression to reduce edema and either plain alginate, or MEDIHONEY® alginate

MEDIHONEY

®

initiated

By WK #2, the wound managed with MEDIHONEY® was reduced by 62%

By WK #3, the wound managed with MEDIHONEY® healed, and the other wound is switched to MEDIHONEY® (heals at WK #4)

Peripheral neuropathy, ESRD, and CCL I

Dense fibrin tissue, slough and limited granulation tissue upon initial presentation

MEDIHONEY

®

initiated

Dressing changes every other day

Wound volume reduced by 25% by WK #4, and by 85% by WK #8. Complete healing by WK #16

Pyoderma

Gangrenosum

Recalcitrant

Diabetic Foot Ulcer

Catherine T. Milne, APRN, MSN, CWOCN: Case #3 of 3 presented at 2008 SAWC & WOCN

Non-healing diabetic foot ulcer WK #8 after initiation of MEDIHONEY®

Medihoney_brochure_9.21.09.indd 5 12/5/11 3:16:28 PM

MEDIHONEY®

Woundcare & Product Selection Chart

For skin protection around exudating wounds use Medihoney™ Barrier Cream NB Secondary dressings should be suffi ciently absorbent to manage exudate levels

5. Cutting KF. Honey and contemporary wound care: An overview. Ostomy Wound Manage. 2007;53(11):49–54. 6. Gethin G, Cowman S. Case series of use of Manuka honey in leg ulceration. Int Wound J. 2005;2(1):10 –15. 7. Gethin G, Cowman S. The impact of Manuka honey dressings on the surface pH of chronic wounds. Int Wound J. 2008; 5:185-194.

1. The Use of MEDIHONEY on surgical wounds post-CABG. Bateman S, Graham T (2007) WOUNDS UK. Vol 3. 76 – 83. 2. Leptospermum scoparium Honey vs. Hydrogel to deslough venous ulcers: A randomised controlled trial. Gethin G. EWMA 2007. 3. Chronic lower extremity venous ulceration – Use of a Leptospermum honey impregnated alginate to facilitate wound closure. Regulski M. SAWC 2008. 4. Wound care with MEDIHONEY in paediatric haematology-oncology. Simon A, Sofka K, Wiszniewsky G, Blaser G, Bode U, Fleischhack G. (2006) Supportive Care in Cancer. 14. (1): 91-7.

• Free Call 1800 269 534 • Free Fax 1800 810 257

• Email [email protected] • Visit www.eboshealthcare.com.au

WOUND CARE & PRODUCT SELECTION CHART

THE ORIGINAL WOUND CARE SOLUTION


WOUND TYPE INFECTED BLACK, NECROTIC YELLOW, SLOUGHY RED, GRANULATION PINK, EPITHELIAL CAVITY OR SINUS/FISTULA MALODOROUS

TREATMENT OBJECTIVE Reduce infection and colonisation

Assists wound healing

Clean wound

Rehydrate

Debride

Wound protection

Remove slough

Rehydrate

Wound protection

Manage exudate

Maintain moist wound bed

Assist wound healing

Wound protection

Manage exudate


Wound protection


Aid granulation


Wound protection

Remove malodour

MODE OF ACTION High osmotic potential helps clean the wound and disperse biofi lms.

Cleaning the wound reduces bacteria loadings, which are a source of infl ammatory endotoxins.

Provides an antibacterial barrier to protect the wound bed.

The osmotic action produces an outfl ow of body fl uid helping to lift debris and remove necrotic tissue.

The moist wound environment reduces the risk of eschar formation.

Provides an antibacterial environment that helps protect the wound.

The high osmotic potential of Antibacterial Medihoney™ wound dressings causes a mass fl ow of bacteria, endotoxins and sloughy material away from the wound bed. This material is then contained in an antibacterial matrix for easy removal at dressing change.

Osmotic action brings fl uid into the wound providing a moist wound environment to assist the granulation process

Antibacterial barrier protects the wound from infection by bacteria.

Provides moist wound environment to encourage the epithelialisation process.

Antibacterial barrier to protect the wound from contamination and reduces risk of colonisation.

Helps reduce oedema, pain and exudate levels and protects exposed tissue from infecting bacteria, reducing the risk of colonisation.

Inhibits the bacteria that cause odour.

Helps clean the wound and lift debris to rapidly reduce odour.

EXUDATE LEVEL Heavy/Moderate

Low/None Heavy/Moderate






Low/None

Medihoney™ Antibacterial Medical Honey™ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓Medihoney™ Antibacterial Wound Gel™ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓Medihoney™ Antibacterial Honey Gel Sheet ✓ ✓ ✓ ✓ ✓ ✓Medihoney™ Antibacterial Honey Alginate ✓ ✓ ✓ ✓ ✓ ✓Medihoney™ Antibacterial Honey Tulle ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓

Medihoney (Europe) LtdPost Box 2205 High StreetMaidenheadSL6 1JNUK Toll free: 0800 071 3912Int Tel: +44 1628 779461 www.medihoney.com

NB Secondary dressings should be suffi ciently absorbent to manage exudate levels

It’s not just any honey

It’s MEDIHONEY™

For skin protection around exudating wounds use Medihoney™ Barrier Cream

For skin protection around exudating wounds use Medihoney™ Barrier Cream NB Secondary dressings should be sufficiently absorbent to manage exudate levels

MEDIHONEY®Wound & Burn Dressing with Leptospermum Honey.

• Free Call 1800 269 534 • Free Fax 1800 810 257

• Email [email protected] • Visit www.eboshealthcare.com.au


THE ORIGINAL WOUND CARE SOLUTION


WOUND TYPE INFECTED BLACK, NECROTIC YELLOW, SLOUGHY RED, GRANULATION PINK, EPITHELIAL CAVITY OR SINUS/FISTULA MALODOROUS

TREATMENT OBJECTIVE Reduce infection and colonisation

Assists wound healing

Clean wound

Rehydrate

Debride

Wound protection

Remove slough

Rehydrate

Wound protection

Manage exudate



Wound protection

Manage exudate


Wound protection


Aid granulation


Wound protection

Remove malodour

MODE OF ACTION High osmotic potential helps clean the wound and disperse biofi lms.

Cleaning the wound reduces bacteria loadings, which are a source of infl ammatory endotoxins.

Provides an antibacterial barrier to protect the wound bed.

The osmotic action produces an outfl ow of body fl uid helping to lift debris and remove necrotic tissue.

The moist wound environment reduces the risk of eschar formation.

Provides an antibacterial environment that helps protect the wound.

The high osmotic potential of Antibacterial Medihoney™ wound dressings causes a mass fl ow of bacteria, endotoxins and sloughy material away from the wound bed. This material is then contained in an antibacterial matrix for easy removal at dressing change.

Osmotic action brings fl uid into the wound providing a moist wound environment to assist the granulation process

Antibacterial barrier protects the wound from infection by bacteria.

Provides moist wound environment to encourage the epithelialisation process.

Antibacterial barrier to protect the wound from contamination and reduces risk of colonisation.

Helps reduce oedema, pain and exudate levels and protects exposed tissue from infecting bacteria, reducing the risk of colonisation.

Inhibits the bacteria that cause odour.

Helps clean the wound and lift debris to rapidly reduce odour.

EXUDATE LEVEL Heavy/Moderate







Low/None

Medihoney™ Antibacterial Medical Honey™ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓Medihoney™ Antibacterial Wound Gel™ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓Medihoney™ Antibacterial Honey Gel Sheet ✓ ✓ ✓ ✓ ✓ ✓Medihoney™ Antibacterial Honey Alginate ✓ ✓ ✓ ✓ ✓ ✓Medihoney™ Antibacterial Honey Tulle ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓

Medihoney (Europe) LtdPost Box 2205 High StreetMaidenheadSL6 1JNUK Toll free: 0800 071 3912Int Tel: +44 1628 779461 www.medihoney.com

NB Secondary dressings should be suffi ciently absorbent to manage exudate levels

It’s not just any honey

It’s MEDIHONEY™

For skin protection around exudating wounds use Medihoney™ Barrier Cream

For skin protection around exudating wounds use Medihoney™ Barrier Cream NB Secondary dressings should be sufficiently absorbent to manage exudate levels

www.eboshealthcare.com.au 9

HEALTHLINES ISSUE #3

The Lightweight Leg Section Plus has been designed to significantly enhance the weight capacity of the original Lightweight Leg Section. The device can easily and safely be attached and removed by a single user.

Key features: � Enhanced patient weight capacity to

accommodate patients up to 300kgs

� Slimmer profile and two-stage attachment and detachment improving user handling

� The profile of the distal portion has been enhanced to provide improved storage

� Velcro free mattress attachment

� Superior attachment security

Technical Data � Maximum patient weight up to 300kgs � 562mm (w) x 850mm (L) � Velcro-free mattress attachment � Supplied with a 50mm thick mattress

attached by straps to the side frames

Eschmann’s Divided Leg Section Plus with Universal Footplates is a highly adaptable device that allows a wide range of patient positions, ensuring easy surgical access.

Key features: � Adjustable to allow abduction and

lateralisation for easy surgical access

� Strong double-axle hinge mechanism for high weight capacity

� Adjustable footplates allow for variations in leg lengths

� Easy clean for cross infection control.

� Suitable for Bariatric surgery requiring high weight capacity

Technical Data � Maximum patient weight up to 325kgs

(Lower patient weight restrictions for T10 tables)

� Divided Leg Section Dimensions: 700mm(L) x 289mm(W) Universal Footplate Dimensions: 309mm(L) x 309mm(W)

� Device weight 21.95kg � Elevation +140 -900

� Abduction 900 in 150 increments

Lightweight Leg Section Plus & Table accessoryfor T Series Tables

Update

Divided Leg Section PlusWith Universal Footplates

Superior Attachment securityThe profile of the distal portion has

been enhanced to provide improved storage

For information on the Eschmann range please contact Kylie Upton:

E: [email protected] Ph: 1800 269 534 Fax: 1800 810 257 Mob: 0412 203 957

* Patient Pending

Its manoeuvrable divided leg section, double-axle

mechanism* and adjustable footplates mean that it can

accommodate a wide range of patient heights and weights.

vt


Reference: www.acipcconference.com.au

AUSTRALASIAN COLLEGE FOR INFECTION PREVENTION AND CONTROL

NATIONAL CONFERENCE 20128-11 OCTOBER 2012 • SYDNEY, AUSTRALIA

The ACIPC 7th Biennial Conference will take place from Monday 8 October to Thursday 11 October 2012 at the Sydney Exhibition and Convention Centre, Darling Harbour, Sydney, Australia. The conference is Australia’s and one of the region’s most important events related to Infection Prevention and Control. It attracts over 500 delegates and 55 trade exhibitors, and is the major educational and networking forum for professionals working in and related to the IP area.

The key theme for this event is ‘building, balancing, believing and beyond’, with a program containing pre-conference workshops and presentations by experts in the infection prevention and control field including well known and highly respected international and national invited keynote speakers. The 2012 ACIP Conference will highlight and build on accomplishments of the recent, past and present research and innovative strategies that will define infection surveillance, prevention and control beyond and into the challenging future for Infection Prevention and Control.

The event will be an excellent opportunity for specialists and trainees with an interest or currently working in Infection Prevention and Control to share skills and experience. Participants will be able to discuss the latest advances and progress from varied viewpoints and the scientific program will contain many internationally respected speakers that will ensure a state-of-the-art, evidence-

based and cutting-edge event.

Among the key speakers this year:

� Hugo Sax; head of infection control program at the University Hospital of Zurich, Switzerland; certified in internal medicine and infectious diseases.

� Andreas Voss; Professor of Infection Control Radboud University Nijmegen Medical Centre; Clinical microbiologist of Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands, and Head of Regional Infection Control Group (i-Prevent).

� Emma Burnett; Lecturer and Researcher in Infection Prevention at the University of Dundee, School of Nursing & Midwifery following 13 years as an Infection Prevention and Control Nurse; member of the Infection Prevention Society Research and Development Committee.

� Dale Fisher; Chair of Infection Control and Head of Infectious Diseases at the National University Hospital, Singapore.

� Peter Hoffman; Consultant Clinical Scientist with the Health Protection Agency’s (HPA) Laboratory of Healthcare associated Infection in London.

� Martin Kiernan; Nurse Consultant in Infection Prevention at Southport and Ormskirk NHS Trust in England. He has worked in the field of infection prevention and control for 22 years. He has a Masters in Public Health (University of Birmingham), currently undertaking a Masters in Clinical Research at the University of Manchester.

Martin Kiernan is also a member of the UK Department of Health Expert Advisory Committee on Antimicrobial Resistance and Healthcare-associated Infection and is the immediate past President of the UK Infection Prevention Society (formerly the Infection Control Nurses Association). His research interests currently centre on surveillance and urinary catheter-associated infections and his other professional interests include wound management, environmental hygiene and human waste disposal methods.

Martin Kiernan currently acts as an independent clinical advisor to Vernacare Ltd in the UK. He will be available to answer questions related to human waste disposal methods, which is the subject of his presentation at the ACIP Conference in Sydney on Tuesday 9th October. Martin will be at the EBOS / Vernacare stand, booths 36 to 39.

www.eboshealthcare.com.au 11


vt


Reference: www.acipcconference.com.au

Martin Kiernan Southport and Ormskirk NHS Trust, UK

PAPER ABSTRACT

“Human Waste Disposal in Clinical Settings: A Review of the Evidence” ACIPC Conference, Tuesday 9th October 3:30pm

Human waste disposal is carried out in every healthcare setting the world over, yet there are considerable differences in the methods and techniques for this common procedure. Human faeces carries a demonstrable risk of environmental contamination with a large variety of potential pathogens including Meticillin-resistant Staphylococcus aureus (MRSA), Vancomicin-resistant enterococci (VRE), emerging highly-resistant gram-negative organisms such as those producing New Delhi Metallobetalactamase (NDM), C. difficile, and Norovirus. Many of these organisms contaminating the environment survive well and are highly transmissible in healthcare settings. Despite these demonstrable risks, human waste disposal methods are an under-researched area and have a limited evidence base.

Internationally, a number of different systems are used to handle human waste. In the USA the use of local cleaning in a patient’s room followed by terminal cleaning is common, local decontamination by the use of a washer-disinfector is found all worldwide, in the UK local disposal by the use of single-use pulp products is the most common method of removal and recently in Canada a plastic bag containment system has been proposed as a potential solution.

This paper will discuss the available evidence and will highlight the positive and negative aspects of each method of disposal, particularly with respect to decontamination facilities and the use of single-use, disposable systems. The discussion will also consider the financial and environmental aspects of each system.

Healthcare Acquired Infections (HAIs) continue to pose a risk to both patients and Healthcare facilities worldwide. The emphasis is now on Healthcare providers to ensure they do all they can to protect patients from HAIs.

Financially HAIs are one of the biggest burdens on any healthcare facility; in Australia they are costing the healthcare system more than $1 Billion a year in lost bed days¹.

The cost to patients, although not financial, is far greater. UK-based research shows that patients with HAIs take an average of 17 days longer to return to their normal daily activities than those without infections and are seven times more likely to die².

An area regularly overlooked but of paramount importance is reducing the risk of cross infection when toileting patients and handling human waste.

One common patient toileting practice is the use of reusable utensils

which are reprocessed in a bedpan washer disinfector. However, Alfa et al³ concluded that ward washer disinfectors may not provide adequate conditions for killing C difficile spores, because they cannot achieve the necessary thermal killing conditions. As such it is important to address issues of decontamination failures.

An alternative single use system is now available, used in over 50 countries, in 94% of UK hospitals and in many Australian healthcare facilities such as the Royal Children’s Hospital in Melbourne, the Vernacare system is an environmentally friendly, time saving and cost effective alternative that can help reduce the risk of cross infection.

In a study at Salford Royal NHS Foundation Trust in 2007, in which the Vernacare disposable washbowl was introduced alongside several other interventions, Power et al4 concluded: “at baseline the non-collaborative wards had 1.15 (95% CI 1.03 to 1.29) cases per 1000 occupied bed days. In August 2007, cases reduced 56% from baseline (0.51, 0.44, 0.60) which has

been maintained since that time.”

Healthcare providers are continually looking for ways to reduce and remove the risk of HAIs.

The Vernacare system, when used as part of a proactive, infection prevention program, can help to reduce the risk of cross infection and not only save healthcare facilities money but also improve patient care and safety.

References: 1. Economic rationale for infection control in Australian hospitals..Nicholas Graves A E, Kate Halton C, David Paterson D, Michael Whitby B Healthcare Infection 14(3) 81–88. 26 August 2009. Queensland University of Technology (2009, September 2). Hospital Infections In Australia Cost $1 Billion In Lost Bed Days. ScienceDaily 2. Plowman R, Graves N, Griffin M et al. The socio-economic burden of hospital acquired infection. London: Public Health Laboratory Service, 2000. 3. Alfa M, Olson N, Buelow-Smith L. Simulated-use testing of bedpan and urinal washer disinfectors. Evaluation of Clostridium difficile spore survival and cleaning efficacy. Winnipeg, Canada. Am J Infect Control 2008:36:5-11. 4. Power, M et al. Reducing Clostridium difficile infection in acute care by using an improvement collaborative. Salford, UK. British Medical Journal 2010;341c3359

PROTECTING PATIENTS FROM HAIs


EBOSOnlineFlyer..indd 1 23/01/12 10:06 AM

12 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] www.eboshealthcare.com.au 13

HEALTHLINES ISSUE #3quality healthcare solutions

Sustainability and resource efficiency are a growing environmental concern across the world. Many organisations are striving to reduce their environmental impact and in the process save money by using less energy and natural resources. Whilst there are numerous ways to save water, one simple solution could be the choice of soap in the washroom.

Dr John hines, R&D Director at skin care experts, Deb group, announced how independent research commissioned by Deb has shown that when using foam soap for hand washing people use 16% less water than when using liquid soap. Dr hines goes on to state that “water consumption can in fact be reduced by up to a staggering 45% by adopting a foam soap hand washing technique of dispense, lather, tap on, rinse”.

For every 100 people employed, the use of foam soap for hand washing can equate to an annual water reduction of up to 56,000 litres. As warm water is usually used there are also savings to be made in energy use and Co2 emissions.

Dr hines also explains that an experiment conducted by Deb shows foam soap is eight times more spreadable than lotion soap and reduces the quantity of product required for an effective hand wash. Interestingly, using less product does not equate to less efficacy as a further scientific study commissioned by Deb shows that there is no significant difference in the cleaning ability between a 0.7ml shot size of Deb foam soap compared to a standard 1.1ml shot size of lotion soap, confirming that the same efficacy is delivered from foam using less product.

Further benefits explained by Dr hines are that foam soap is more biodegradable than lotion soap as it does not require chemicals to thicken the soap - the lather is created by adding air. In addition, as foam soap delivers more hand washes from the same packaging compared to lotion soaps, it means that products have to be replaced less often, ultimately saving time and money and reducing packaging waste.

Dr hines concludes by stating he “would seriously urge any organisation to consider the use of foam soap to help reduce their environmental impact and at the same time save time and money”.

REFERENCE:“how a simple change in the washroom can significantly reduce water consumption and associated costs”; Ann Durrant and Alexandra McKay, Media4change (UK) ltd

EBo

• lather is created by adding air, not chemicals.• more handwashes for the same packaging (replace less often)= Saves water, time, money and reducing packaging waste

WHy cHooSe deb Foam

Soap?

• uses up to 45% less water

• 8 x more spreadable than

lotion soap

• biodegrable- does not

require chemicals to

thicken soap.

1¢PeRSHOT

HOW A SIMPLE WASHROOM SOLUTION SAVES WATER, TIME AND MONEy

Distributed by:


CASE STUDY

Great Ormond Street Hospital in London is the world’s leading children’s hospital and holds patient safety in the highest regard. Its mission is to provide world-class clinical care and training, pioneering new research and treatments in partnership with others for the benefit of children in the UK and worldwide.

Vernacare UK, global supplier of human waste management solutions in healthcare and global leader in this sector, were delighted to provide Great Ormond Street Hospital with a solution to help improve efficiency, reduce the risk of cross-infection, and, most importantly, allow nurses to spend more time with patients.

The hospital recently overhauled patient toileting in order to advance standards of infection prevention, removing bedpan washers and older pulp disposal units and replacing them with the Vernacare Vortex macerator.

A major factor behind the change of system was that the existing bedpan washers had to be checked weekly to comply with regulations and standards. This had a huge impact on the maintenance department in relation to time and resource.

“The convenience and efficiency of the Vernacare system means that nurses can concentrate on other more important duties like caring for the patient.” Deirdre Malone

Deirdre Malone, Lead Nurse Infection Control and Deputy Director of Infection Prevention and Control, Great Ormond Street Hospital, said, “Our focus is around patient safety. It is not always possible to guarantee that bedpan washers were reaching appropriate

temperatures and therefore there was a risk that bacteria and spores were not destroyed. The hospital chose the Vernacare Vortex macerator because it offers a full single use system in which pulp products are used.”

The Vortex ensures that the soiled pulp bedpan is completely removed from the ward by means of breaking down the pulp in a closed, secure, safe process, with the remaining waste emptied out through the drainage system.

Improving Hospitals Efficiency at Great Ormond Street Hospital, London.



An award winning organisation,established for nearly 50 years, Vernacareprovides single use pulp products and the Vortex disposal unit for human wastemanagement for patients who are notfully mobile.

This system is a best practice methodused in over 50 countries and by 94% of UK Hospitals. The Vernacare system is an environmentally friendly, time savingand cost effective alternative that canhelp reduce the risk of cross infection.

Vernacare products are manufactured inaccordance with the highest standardsand carry the BSI Kitemark. Vernacareproduce millions of medical pulpmouldings per year and have recentlywon the prestigious Q ueen’s Award forEnterprise for our detergent proofwashbowl.

In addition, the business supplies a wide range of complementary infection control products including:Vernachair commode, Tuffie cleaning anddisinfecting wipes and Senset cleansingfoam and patient wipes.

Together with our global network ofVernacare distribution partners weprovide customer support via ward basedtraining, educational tools and technicalengineering services to the support theuse of the Vernacare system.

Vernacare specialises in the design, manufacture and supply of products to healthcarefacilities around the world which help to reduce the risk of cross infection.

may supporta reduction in

HCAI’s*

uses

60%less water

uses

94.5%less power

36%saving in operational costs

The Vernacare single use system delivers many benefits compared to alternative systems, including:

estimated

33%time saving

VernacareCaseStudyP2.pdf 1 24/07/12 12:43 PM

CASE STUDY

* A 56% reduction in HCAI’s was achieved by using Vernacare disposable washbowls alongside other interventions reducing Clostridium Difficile infection in acute care by using an improvement collaborative, Power M, Wigglesworth N et al, Salford Royal NHS Foundation Trust, UK, BMJ 2010; 341: c3359

16 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected] 1 30/05/12 8:55 AM



Tuffie 5multi-surface disinfectant wipes

Tuffie 5 Wipes - 225 Tub - Flexican - Dispenser RefillMulti-surface cleaning and disinfectant wipes.

Wipes DispenserWall-mounted dispensers save space in crowded areas by removing tubs and buckets from cluttered surfaces. The easy way to use Tuffie Wipes whenever you need them.

Tuffie 5 wipes hospital grade

disinfectant wipes for cleaning

and disinfection of hard

surfaces and equipment.

The formulation combined with

mechanical action when using

the wipe aids the removal of

organic matter and improves

infection prevention and control.

Tuffie 5 wipes are suitable for

use on all hard surfaces where

cleanliness and eradication of

bacteria are required.

Alcohol and Chlorine FREE


Gloves

Saline Solutions

Examination Gloves in vinyl, latex and nitrile in a wide range of sizes

Quality Medical Consumables. Make InHealth your choice

Saline Solutions in EasyPour and Normal T Top Packaging

Code Product UnitSALINE SOLUTIONS19220025 Normal 30ml Box/2419220026 Normal T Top 100ml Each19220027 Normal T Top 500ml Each19220028 EasyPour 500ml Each19220029 EasyPour 1L Each

Code Product UnitPOWDER FREE VINYL GLOVESEBPFVS100 SMALL Box/100EBPFVM100 MEDIUM Box/100EBPFVL100 LARGE Box/100POWDER FREE NITRILE GLOVESEBNGS150 SMALL Box/100EBNGM150 MEDIUM Box/100EBNGL150 LARGE Box/100EBNGXL150 X LARGE Box/100POWDER FREE LATEX GLOVESEBPFGXS100 X SMALL Box/100EBPFGS100 SMALL Box/100EBPFGM100 MEDIUM Box/100EBPFGL100 LARGE Box/100


HEALTHLINES ISSUE #3Gloves Saline Solutions Autoclave pouches Electrodes Urine drainage bags

Autoclave Pouches

Electrodes

Urine Drainage Bags

Self Sealing Autoclave Pouches in a variety of sizes

Basic and Closed System Urine Drainage Bags

Code Product UnitAUTOCLAVE POUCHESSIHSS7025 70x257mm Box/200SIHSS9016 90x162mm Box/200SIHSS9025 90x257mm Box/200SIHSS1328 135x283mm Box/200SIHSS1935 190x358mm Box/200SHISS3038 300x380mm Box/200

Code Product UnitELECTRODES19220005 Resting Tab Electrode Pkt/10019220001 PE Foam Monitoring Electrode Pkt/5019220004 Fabric Back Monitoring Electrode Pkt/50

Code Product UnitBASIC URINE DRAINAGE BAGS

SB320902 (S2) Non Drainable 2 Litre Drainage Bag (non sterile) Each

SB331108 (S3) 2 Litre Drainage Bag with Outlet (non-sterile) Each

CLOSED SYSTEM BAG

SB340821 (S4) Sterile 2 Litre Drainage Bag 120cm inlet tube Each


a

Kerry BlewittKerry has been working for EBOS for over 3 years as Key Account Manager for our Infection

Prevention Division.

Kerry enjoys offering the best possible customer service and creating supportive and beneficial relationships with her customers. She also enjoys meeting caring, interesting and intelligent people,

which she says it’s something that fortunately happens quite often in her line of work.

Her greatest achievements in the role so far were winning over 2 important customers who were purchasing other pulp consumables (i.e. not the Vernacare brand distributed exclusively by EBOS). This

year both customers are happy to be on board with EBOS as their supplier of choice.

In the future Kerry is looking forward to assisting hospitals with the trial and implementation of the most economical and environmentally friendly human waste disposal system on the market. The installation of the

Vernacare Vortex Macerators will not only help hospitals to save dollars through energy and water savings, it will also help reducing the spread of hospital acquired infections.

The highlight of the last year for Kerry was when she had to perform CPR on an elderly gentleman who was having a heart attack in a shopping centre car park. Kerry said “When I got to him he was blue, I worked on him for 20 minutes until

the ambulance finally arrived and took over”. All ended well and he survived.

...for Mr & Mrs C.Diff. and a few more

unpleasant guests...

FREE 4 WEEKS SUPPLY OF PRODUCT

VERNACARE PULP WASHBOWL

Contact your IP Account Manager for details on this trial offer or email [email protected]

Documents

EBOS Healthcare Hospital Newsletter - Vital Med · 6 EBOS Healthcare Hospital Division. For more information please Phone: 1800 269 534 or Email: [email protected]